Gene · 9507
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Colchicine protects against cartilage degeneration by inhibiting MMP13 expression via PLC-γ1 phosphorylation. | Osteoarthritis Cartilage | 2021 | 34425229 | PubTator, text mining | PubMed |
| Diagnostic and Therapeutic Role of Extracellular Vesicles in Articular Cartilage Lesions and Degenerative Joint Diseases. | Front Bioeng Biotechnol | 2021 | 34422779 | PubTator, text mining | PubMed |
| Protective role of the alpha-1-antitrypsin in intervertebral disc degeneration. | J Orthop Surg Res | 2021 | 34416893 | PubTator, text mining | PubMed |
| Neural Tissue Homeostasis and Repair Is Regulated via CS and DS Proteoglycan Motifs. | Front Cell Dev Biol | 2021 | 34409033 | PubTator, text mining | PubMed |
| 4-Methylumbelliferone suppresses catabolic activation in anterior cruciate ligament-derived cells via a mechanism independent of hyaluronan inhibition. | J Orthop Surg Res | 2021 | 34404442 | PubTator, text mining | PubMed |
| Bioinformatics Analysis and Functional Verification of ADAMTS9-AS1/AS2 in Lung Adenocarcinoma. | Front Oncol | 2021 | 34395250 | PubTator, text mining | PubMed |
| Suramin attenuates intervertebral disc degeneration by inhibiting NF-κB signalling pathway. | Bone Joint Res | 2021 | 34372688 | PubTator, text mining | PubMed |
| Peptide-Based Inhibitors of ADAM and ADAMTS Metalloproteinases. | Front Mol Biosci | 2021 | 34368231 | PubTator, text mining | PubMed |
| Magnoflorine Alleviates "M1" Polarized Macrophage-Induced Intervertebral Disc Degeneration Through Repressing the HMGB1/Myd88/NF-κB Pathway and NLRP3 Inflammasome. | Front Pharmacol | 2021 | 34366853 | PubTator, text mining | PubMed |
| Inverse Agonist of Retinoid-Related Orphan Receptor-Alpha Prevents Apoptosis and Degeneration in Nucleus Pulposus Cells via Upregulation of YAP. | Mediators Inflamm | 2021 | 34366712 | PubTator, text mining | PubMed |
| Anti-Inflammatory Therapeutic Approaches to Prevent or Delay Post-Traumatic Osteoarthritis (PTOA) of the Knee Joint with a Focus on Sustained Delivery Approaches. | Int J Mol Sci | 2021 | 34360771 | PubTator, text mining | PubMed |
| Males and Females Have Distinct Molecular Events in the Articular Cartilage during Knee Osteoarthritis. | Int J Mol Sci | 2021 | 34360640 | PubTator, text mining | PubMed |
| BNIP3-Dependent Mitophagy via PGC1α Promotes Cartilage Degradation. | Cells | 2021 | 34360007 | PubTator, text mining | PubMed |
| The Role of miRNAs in Extracellular Matrix Repair and Chronic Fibrotic Lung Diseases. | Cells | 2021 | 34359876 | PubTator, text mining | PubMed |
| Association between miRNA Target Sites and Incidence of Primary Osteoarthritis in Women from Volga-Ural Region of Russia: A Case-Control Study. | Diagnostics (Basel) | 2021 | 34359306 | PubTator, text mining | PubMed |
| Intervertebral Disk Degeneration: The Microenvironment and Tissue Engineering Strategies. | Front Bioeng Biotechnol | 2021 | 34354983 | PubTator, text mining | PubMed |
| Chondrocyte Aging: The Molecular Determinants and Therapeutic Opportunities. | Front Cell Dev Biol | 2021 | 34336816 | PubTator, text mining | PubMed |
| MicroRNA-486 promotes a more catabolic phenotype in chondrocyte-like cells by targeting SIRT6 : possible involvement in cartilage degradation in osteoarthritis. | Bone Joint Res | 2021 | 34319136 | PubTator, text mining | PubMed |
| Etomidate ameliorated advanced glycation end-products (AGEs)-induced reduction of extracellular matrix genes expression in chondrocytes. | Bioengineered | 2021 | 34308765 | PubTator, text mining | PubMed |
| Prediction of a Potential Mechanism of Intervertebral Disc Degeneration Based on a Novel Competitive Endogenous RNA Network. | Biomed Res Int | 2021 | 34307661 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9507/papers?page=38